Cabaletta Bio, Inc.
看多

Nice Pattern Developing

181
Cabaletta Bio is an early stage biotech. Keep an eye on breakout of pattern.
Stock could have huge upside potential due to novel approach of using
CAR-T Cell technology for Auto-Immune disease where as most have used it just for
cancer drugs

免責聲明

這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。